Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/183266
Title: The Expression of TP53-Induced Glycolysis and Apoptosis Regulator (TIGAR) Can Be Controlled by the Antioxidant Orchestrator NRF2 in Human Carcinoma Cells
Author: Simon Molas, Helga
Sánchez de Diego, Cristina
Navarro i Sabaté, Àurea
Castaño Boldú, Esther
Ventura Pujol, Francesc
Bartrons Bach, Ramon
Manzano Cuesta, Anna
Keywords: Cèl·lules canceroses
Estrès oxidatiu
Metabolisme
Apoptosi
Glucòlisi
Cancer cells
Oxidative stress
Metabolism
Apoptosis
Glycolysis
Issue Date: 8-Feb-2022
Publisher: Ivyspring International
Abstract: Hyperactivation of the KEAP1-NRF2 axis is a common molecular trait in carcinomas from different origin. The transcriptional program induced by NRF2 involves antioxidant and metabolic genes that render cancer cells more capable of dealing with oxidative stress. The TP53-Induced Glycolysis and Apoptosis Regulator (TIGAR) is an important regulator of glycolysis and the pentose phosphate pathway that was described as a p53 response gene, yet TIGAR expression is detected in p53-null tumors. In this study we investigated the role of NRF2 in the regulation of TIGAR in human carcinoma cell lines. Exposure of carcinoma cells to electrophilic molecules or overexpression of NRF2 significantly increased expression of TIGAR, in parallel to the known NRF2 target genes NQO1 and G6PD. The same was observed in TP53KO cells, indicating that NRF2-mediated regulation of TIGAR is p53-independent. Accordingly, downregulation of NRF2 decreased the expression of TIGAR in carcinoma cell lines from different origin. As NRF2 is essential in the bone, we used mouse primary osteoblasts to corroborate our findings. The antioxidant response elements for NRF2 binding to the promoter of human and mouse TIGAR were described. This study provides the first evidence that NRF2 controls the expression of TIGAR at the transcriptional level.
Note: Reproducció del document publicat a: https://doi.org/10.3390/ijms23031905
It is part of: International Journal of Medical Sciences, 2022, vol. 23, num. 3
URI: http://hdl.handle.net/2445/183266
Related resource: https://doi.org/10.3390/ijms23031905
ISSN: 1449-1907
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
Articles publicats en revistes (Ciències Fisiològiques)

Files in This Item:
File Description SizeFormat 
719266.pdf3.76 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons